Medivolve Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	n/a
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	4.6yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Medivolve no tiene CEO, o no tenemos datos al respecto.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Michael McCarthy	Member of Advisory Board	4.6yrs	sin datos	sin datos
James Beeland Rogers	Member of Strategic Advisory Board	4.6yrs	sin datos	sin datos
Joseph Sugerman	Member of Advisory Board	4.5yrs	sin datos	sin datos
Glenn Copeland	Member of Advisory Board	no data	sin datos	sin datos
Richard Dolan	Member of Strategic Advisory Board	4.6yrs	sin datos	sin datos
Paulo Iglessias	Member of Advisory Board	4.6yrs	sin datos	sin datos
Mike Mancias	Member of Advisory Board	4.6yrs	sin datos	sin datos

4.6yrs

Permanencia media

Junta con experiencia: La junta directiva de MEDV.F se considera experimentada (4.6 años de antigüedad promedio).

Medivolve Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Medivolve Inc. Announces Resignation of David Preiner as Chief Executive Officer

Medivolve Inc. Announces Resignation of Peter Michel as Chief Financial Officer

Medivolve Inc. Announces the Resignation of Wen Ye as Board of Director

Medivolve Inc. Announces the Resignation of Beverley Richardson from its Board of Directors

Medivolve Inc. Announces Chief Financial Officer Changes

Beverly Richardson Joins Questcap’s Board of Directors

Recent updates

Medivolve Inc. Announces Resignation of David Preiner as Chief Executive Officer

Medivolve Inc. Announces Resignation of Peter Michel as Chief Financial Officer

Medivolve Inc. Announces the Resignation of Wen Ye as Board of Director

Medivolve Inc. Announces the Resignation of Beverley Richardson from its Board of Directors

Medivolve Inc. announced that it expects to receive CAD 4 million in funding

Medivolve Inc. announced that it has received CAD 1.2 million in funding

Medivolve Inc. Announces Chief Financial Officer Changes

Medivolve Inc. announced that it expects to receive CAD 2.6 million in funding

Medivolve Announces New COVID-19 Testing Mobile Vans Expanding On-Site Testing Opportunities to Schools, Workplaces, and Events

Medivolve Inc. announced that it has received CAD 12 million in funding

Medivolve Inc. (OTCPK:COPR.F) completed the acquisition of Electronic Health Platform of Myosin Inc.

Medivolve Inc. (OTCPK:COPR.F) signed a binding agreement to acquire Marbella Pharmacy for $0.5 million.

Medivolve Inc. and Marvel Diagnostics Inc. Complete First Stage Clinical Testing of BlowFISH

Medivolve Inc. Launches Business to Business Sales Initiatives

Medivolve Inc. (OTCPK:COPR.F) has signed a letter of intent to acquire Modern Rx LLC for $0.35 million.

Medivolve Inc. Announces the Launch of an Operating Model with Besser Brands in the State of Florida

Medivolve Inc. (NEOE:MEDV) signed a binding letter of intent to acquire Karland Health, LLC.

Medivolve Inc Collection Sites Provides Update with January Sales of 73,973 Tests At an Average Price of $96 Per Test

Medivolve Inc. (NEOE:MEDV) entered into an agreement to acquire Noble Bioscience Corp.

Medivolve Inc. (NEOE:MEDV) entered into a share purchase agreement to acquire a 13.2% stake in Marvel Diagnostics Inc. for $0.33 million.

Medivolve Inc. announced that it has received CAD 5 million in funding

Beverly Richardson Joins Questcap’s Board of Directors

QuestCap Provides COVID-19 Testing Kits to Kinross Gold’s Russian Operations

QuestCap Inc. announced that it expects to receive CAD 5 million in funding

QuestCap Inc. Sign Fifteen Lease Agreements Between Collection Sites, Llc and Orange County, and H&S Energy, Llc to Begin the Roll Out Network of Pop-Up Covid-19 Testing Sites

QuestCap Inc. (CNSX:QSC) completed the acquisition of Collection Sites, LLC.

QuestCap Inc. (CNSX:QSC) entered into a binding letter of intent to acquire Collection Sites, LLC for CAD 2.8 million.

QuestCap Inc. (CNSX:QSC) entered into arm's length agreement to acquire 40% stake in Spectral Analytics, Inc. for $2 million.

QuestCap Inc. (CNSX:QSC) acquired 40% issued and outstanding shares in Amino Therapeutics, Inc.

QuestCap Inc. (CNSX:QSC) completed the acquisition of 49% stake in Athletics and Health Solutions Inc.

QuestCap Inc. (CNSX:QSC) entered into a binding letter of agreement to acquire 28% stake in Sanaty IPS S.A.S. from Latin-Canada Pharma Inc. for CAD 2.7 million.

CEO

Miembros de la Junta

Permanencia media